Epidemiology and clinical biostatistics
2022 Activity indicators
- 2 national public competitive projects led by: ISCIII
- 1 competitive European grant led by: JRC Tender
- 3 private projects led
- 4 competitive HR contracts
- 51 publications
- IF: 629,49
- Q1 publications: 36 (71%)
- D1 publications: 20 (39%)
- 4 supervised doctoral theses read
- Evaluators in different national institutions: 3 researchers.
- Members of Editorial Committees: 1 PI.
- 2 books with registered ISBN (978-84-09-04309 and 978-84-09-04308) on MAPAC algorithms.
- 2 IP registrations: Metadisc 2.0 application no.: 2110269633104 and APP MAPAC-DX application no.: 2211082593771)
- 1 European patent application for an EIT Health project (EP21383224.9) "Chronic pain: Electrical Quantitative Sensory Assessment System for Failed Back Surgery Syndrome".
- 2 visitors hosted and +1 month stay:
- University of Birmingham (UK)
- Fundación Universitaria Ciencias de la Salud (Bogota, Colombia)
Milestones
- Launch of Meta-Disc 2.0 Software for meta-analysis of diagnostic accuracy studies (www.metadisc.es)
- Launch of the MAPAC-DX App for mobile devices on the appropriateness of requests for imaging tests with ionising radiation in hospital emergency departments.
- Success in the competitive call of the European Union for the development and updating of Clinical Practice Guidelines on prevention and diagnosis of Colorectal Cancer and Breast Cancer.
- Publication of a study in the special issue of the Lancet Journal on inequalities and racial differences in healthcare and health outcomes (December 2022)
- Publication of RIPI-f (Reporting Integrity of Psychological Interventions delivered face-to-face) tool in the Journal of Clinical Epidemiology (November 2022)
Bibliometrics
Articles | Accum. FI | Mean | Articles Q1 or Q2 | % in Q1 or Q2 | Articles D1 | % in D1 | |
---|---|---|---|---|---|---|---|
2018 | 42 | 223,5 | 5,32 | 34 | 81 | 17 | 40 |
2019 | 64 | 432,67 | 6,76 | 45 | 70 | 19 | 30 |
2020 | 58 | 279,19 | 4,81 | 38 | 66 | 20 | 34 |
2021 | 64 | 394,78 | 6,17 | 47 | 73 | 17 | 27 |
2022 | 51 | 629,49 | 14,31 | 40 | 78 | 20 | 39 |
279 | 1959,67 | 7,47 | 204 | 73 | 93 | 33 |
*Only original articles, editorials, guidelines and reviews.